4//SEC Filing
Micallef Jacob Vincent 4
Accession 0001078782-20-001006
CIK 0000093314other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:18 PM ET
Size
8.2 KB
Accession
0001078782-20-001006
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Micallef Jacob Vincent
Chief Scientific Officer
Transactions
- Gift
Stock Option (Right to Buy)
2020-12-22−125,000→ 0 total(indirect: Borlaug Limited)Exercise: $4.00From: 2017-04-15Exp: 2022-04-15→ Common Stock (125,000 underlying) - Gift
Stock Option (Right to Buy)
2020-12-22+125,000→ 125,000 totalExercise: $4.00From: 2017-04-15Exp: 2022-04-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option to purchase an aggregate of 125,000 shares of Common Stock of VolitionRx Limited (the "Issuer"), was granted to Dr. Micallef on April 15, 2016 under the Issuer's 2015 Stock Incentive Plan and transferred to Borlaug Limited ("Borlaug"), a consulting firm, on April 20, 2016. Dr. Micallef is a controlling director of Borlaug and has voting and dispositive control over the Common Stock issuable to Borlaug upon the exercise of the option. The option was then transferred by Borlaug to Dr. Micallef on December 22, 2020.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001651671
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:18 PM ET
- Size
- 8.2 KB